G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 27.75 SEK 3.74% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genovis AB
Total Current Liabilities Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Total Current Liabilities
kr18.8m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
13%
AddLife AB
STO:ALIF B
Total Current Liabilities
kr4.3B
CAGR 3-Years
35%
CAGR 5-Years
23%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Total Current Liabilities
kr847m
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Total Current Liabilities
kr648m
CAGR 3-Years
31%
CAGR 5-Years
24%
CAGR 10-Years
20%
MedCap AB (publ)
STO:MCAP
Total Current Liabilities
kr331.9m
CAGR 3-Years
11%
CAGR 5-Years
6%
CAGR 10-Years
3%
M
Magle Chemoswed Holding AB
STO:MAGLE
Total Current Liabilities
kr68.3m
CAGR 3-Years
13%
CAGR 5-Years
-6%
CAGR 10-Years
N/A

See Also

What is Genovis AB's Total Current Liabilities?
Total Current Liabilities
18.8m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Total Current Liabilities amounts to 18.8m SEK.

What is Genovis AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
13%

Over the last year, the Total Current Liabilities growth was 8%. The average annual Total Current Liabilities growth rates for Genovis AB have been 12% over the past three years , 12% over the past five years , and 13% over the past ten years .

Back to Top